People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at least two oral ...

There was no effect of insulin in the larger cohort using the second device. In a subsequent Phase 2 study to determine how much insulin entered the brain after nasal delivery, 19 people received 40 ...

Tanning nasal spray contains what is known as melanotan II, an ingredient that causes the skin to become more tan when exposed to ultraviolet (UV) light. Melanotan II is not approved for any use and ...

A runny nose just might be a runny nose, but a CSF leak could still be a possible cause of your nasal discharge. Amanda MacMillan is a health and science writer and editor. Her work appears across ...

In cases of larger polyps or more severe inflammation, a doctor may prescribe steroid tablets, either on their own or for taking along with a nasal spray. Surgery is only an option if the polyps ...